Back to search
FDAFDA · Food and drugs·Recall number D-0762-2022

Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.

Published April 13, 2022 · Recall initiated: March 10, 2022

Summary

FDA records drug Class III recall D-0762-2022, published April 13, 2022 and initiated March 10, 2022. Recalling firm: Macleods Pharma Usa Inc; Status: Terminated; Reported quantity: 4872 bottles; Lot: Lot #: BRD2001A, Exp 5/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

FAILED CONTENT UNIFORMITY SPECIFICATIONS

What to do

Voluntary: Firm initiated · Letter

Get an email if RISEDRONATE SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
RISEDRONATE SODIUM
Manufacturer
Macleods Pharma Usa Inc
Distributor
USA Nationwide
Lot
Lot #: BRD2001A, Exp 5/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07. recalled?

Yes. FDA published recall D-0762-2022 on April 13, 2022. Reported hazard: FAILED CONTENT UNIFORMITY SPECIFICATIONS

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: RISEDRONATE SODIUM.